DCLK3 and fungal infectious disease: Notably, similar strategies targeting the PD-L1–CLEC7A axis have been shown to restore neutrophil mobilization and reduce susceptibility to fungal infection (Yu et al., 2022), highlighting the feasibility of targeting CLR-related pathways pharmacologically.